Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry

Michael Guger; Christian Enzinger; Fritz Leutmezer; Jörg Kraus; Stefan Kalcher; Erich Kvas; Thomas Berger; Austrian MS Treatment Registry (AMSTR)

doi:10.1007/s00415-019-09535-2

Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry

J Neurol. 2019 Nov;266(11):2678. doi: 10.1007/s00415-019-09535-2.

Authors

Michael Guger¹, Christian Enzinger², Fritz Leutmezer³, Jörg Kraus^{4

5}, Stefan Kalcher⁶, Erich Kvas⁷, Thomas Berger³; Austrian MS Treatment Registry (AMSTR)

Affiliations

¹ Clinic for Neurology 2, Med Campus III, Kepler University Clinic, Krankenhausstrasse 9, 4021, Linz, Austria. Michael.Guger@kepleruniklinikum.at.
² Department of Neurology, Medical University of Graz, Graz, Austria.
³ Department of Neurology, Medical University of Vienna, Vienna, Austria.
⁴ Department of Laboratory Medicine, Paracelsus Medical University and Salzburger Landeskliniken, Salzburg, Austria.
⁵ Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
⁶ Hermesoft, Data management, Graz, Austria.
⁷ Hermesoft, Statistics, Graz, Austria.

PMID: 31531765
DOI: 10.1007/s00415-019-09535-2

Abstract

The original version of this article unfortunately contained a mistake. First and last names of the authors were interchanged. The correct author names are given below.

Publication types

Published Erratum